OLR1 and metastatic malignant neoplasm in the lymph nodes: All 100 patients were included in this study as described in Table 1, and the high expression of LOX-1 in the patients with GC was strongly associated with higher invasion depth (P = 0.016), lymph node metastasis (P = 0.021), and TNM stage (P = 0.006).